Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC3114B in Adults Aged 65 Years or Older
NCT07883928Phase 3Not yet recruiting
- Sponsor
- GC Biopharma Corp
- Start
- Oct 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 3 trial of GC3114B in influenza, sponsored by GC Biopharma Corp. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
GC3114B
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07883928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07883928.